Birdwatch Note
2024-04-21 16:16:14 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
ワクチンの当時の無症状感染・有症状感染・重症化予防はランダム化比較試験のメタ解析レベルで勿論、確認済です。 https://www.carenet.com/news/general/carenet/56042 https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247%2822%2900390-1/fulltext 後遺症に関してはオミクロンの前は勿論のこと、オミクロン期に絞っても完全接種者でわずか(3割程度)に接種者は新型コロナウイルス感染後の症状が続くリスクが低かった事がメタアナリシスによりわかっています。 オミクロン期の結果は下記論文のtable 2の4つ目の項目です。 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1781963676058267771
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1782080916875325892
- noteId - 1782080916875325892
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1713716174702
- tweetId - 1781963676058267771
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- ワクチンの当時の無症状感染・有症状感染・重症化予防はランダム化比較試験のメタ解析レベルで勿論、確認済です。 https://www.carenet.com/news/general/carenet/56042 https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247%2822%2900390-1/fulltext 後遺症に関してはオミクロンの前は勿論のこと、オミクロン期に絞っても完全接種者でわずか(3割程度)に接種者は新型コロナウイルス感染後の症状が続くリスクが低かった事がメタアナリシスによりわかっています。 オミクロン期の結果は下記論文のtable 2の4つ目の項目です。 https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/effectiveness-of-covid19-vaccine-in-the-prevention-of-postcovid-conditions-a-systematic-literature-review-and-metaanalysis-of-the-latest-research/A0B115B5D3AA60846799857B801D116E
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-04-21 16:16:14 UTC (1713716174702) |
2024-04-22 01:19:08 UTC (1713748748422) |
CURRENTLY_RATED_HELPFUL | 2024-04-22 13:33:39 UTC (1713792819406) |
NEEDS_MORE_RATINGS | 2024-04-22 01:19:08 UTC (1713748748422) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-04-21 19:44:10 -0500 | Rating Details | |
2024-04-21 18:01:17 -0500 | Rating Details | |
2024-04-21 17:38:26 -0500 | Rating Details | |
2024-04-21 17:03:27 -0500 | Rating Details | |
2024-04-21 16:26:19 -0500 | Rating Details | |
2024-04-21 14:16:18 -0500 | Rating Details | |
2024-04-21 12:24:04 -0500 | Rating Details | |
2024-04-21 11:41:04 -0500 | Rating Details | |
2024-04-22 06:48:27 -0500 | Rating Details | |
2024-04-21 23:35:46 -0500 | Rating Details | |
2024-04-21 22:00:48 -0500 | Rating Details | |
2024-04-23 17:55:54 -0500 | Rating Details | |
2024-04-22 02:00:35 -0500 | Rating Details | |
2024-04-22 01:28:18 -0500 | Rating Details | |
2024-04-21 21:19:50 -0500 | Rating Details | |
2024-04-21 19:01:03 -0500 | Rating Details | |
2024-04-21 17:33:08 -0500 | Rating Details | |
2024-04-21 17:27:08 -0500 | Rating Details | |
2024-04-21 17:19:01 -0500 | Rating Details | |
2024-04-21 17:12:24 -0500 | Rating Details | |
2024-04-21 17:03:06 -0500 | Rating Details | |
2024-04-21 16:52:20 -0500 | Rating Details | |
2024-04-21 16:42:04 -0500 | Rating Details | |
2024-04-21 16:37:59 -0500 | Rating Details | |
2024-04-21 16:29:28 -0500 | Rating Details | |
2024-04-21 16:21:28 -0500 | Rating Details | |
2024-04-21 15:44:56 -0500 | Rating Details | |
2024-04-21 13:34:24 -0500 | Rating Details | |
2024-04-21 13:08:09 -0500 | Rating Details | |
2024-04-21 11:56:42 -0500 | Rating Details | |
2024-04-21 11:45:46 -0500 | Rating Details | |
2024-04-21 11:39:35 -0500 | Rating Details | |
2024-04-23 15:03:20 -0500 | Rating Details | |
2024-04-22 05:30:46 -0500 | Rating Details | |
2024-04-22 02:50:06 -0500 | Rating Details | |
2024-04-21 22:57:40 -0500 | Rating Details | |
2024-04-21 20:35:30 -0500 | Rating Details | |
2024-04-21 19:51:11 -0500 | Rating Details | |
2024-04-21 19:47:39 -0500 | Rating Details | |
2024-04-21 19:41:49 -0500 | Rating Details | |
2024-04-21 19:36:15 -0500 | Rating Details | |
2024-04-21 18:39:52 -0500 | Rating Details | |
2024-04-21 18:01:27 -0500 | Rating Details | |
2024-04-21 16:47:21 -0500 | Rating Details | |
2024-04-21 15:43:33 -0500 | Rating Details | |
2024-04-21 15:16:33 -0500 | Rating Details | |
2024-04-21 15:16:30 -0500 | Rating Details | |
2024-04-21 14:49:10 -0500 | Rating Details | |
2024-04-21 14:03:23 -0500 | Rating Details | |
2024-04-21 13:22:09 -0500 | Rating Details | |
2024-04-21 12:13:04 -0500 | Rating Details | |
2024-04-23 16:12:42 -0500 | Rating Details | |
2024-04-21 21:41:57 -0500 | Rating Details | |
2024-05-12 10:51:30 -0500 | Rating Details | |
2024-04-23 14:48:02 -0500 | Rating Details | |
2024-04-22 08:04:16 -0500 | Rating Details | |
2024-04-22 02:01:55 -0500 | Rating Details | |
2024-04-21 19:18:13 -0500 | Rating Details | |
2024-04-21 18:45:58 -0500 | Rating Details | |
2024-04-21 17:45:52 -0500 | Rating Details | |
2024-04-21 16:54:29 -0500 | Rating Details | |
2024-04-21 16:41:35 -0500 | Rating Details | |
2024-04-21 16:39:18 -0500 | Rating Details | |
2024-04-21 16:39:14 -0500 | Rating Details | |
2024-04-21 14:44:34 -0500 | Rating Details | |
2024-04-21 14:37:06 -0500 | Rating Details | |
2024-04-21 14:15:30 -0500 | Rating Details | |
2024-04-21 13:15:01 -0500 | Rating Details | |
2024-04-21 13:02:11 -0500 | Rating Details | |
2024-04-21 12:33:13 -0500 | Rating Details | |
2024-04-21 12:25:56 -0500 | Rating Details | |
2024-04-21 12:08:22 -0500 | Rating Details | |
2024-04-21 12:00:55 -0500 | Rating Details | |
2024-04-21 11:39:19 -0500 | Rating Details | |
2024-04-21 11:35:48 -0500 | Rating Details | |
2024-04-21 11:28:54 -0500 | Rating Details | |
2024-04-21 11:28:14 -0500 | Rating Details |